ReEngage Therapeutics, Inc. — Form D
ReEngage Therapeutics, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-12-16. The offering totals $3.0M, of which $65K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2024-12-16
- Form: D
- Accession: 0002022524-24-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $65K
- Remaining: $2.9M
- Investors: 5
- Date of first sale: 2024-12-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-532192
Issuer
- Name: ReEngage Therapeutics, Inc.
- CIK: 0002022524
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 2450 HOLCOMBE BLVD. SUITE 1200, HOUSTON, TX, 77021
- Phone: 215-400-0133
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Thomas Kim | Director | Houston, TX |
| Thomas Kim | Executive Officer | Houston, TX |
Other filings by this issuer (2)
More